Last reviewed · How we verify
NCT05389397: DESIRE
De-implementation of Outdated Colonoscopy Surveillance Interval Recommendations Among Patients With Low-risk Adenomas
NA trial testing Outreach in Polyp of Colon in 604 participants. Completed in 8 September 2023.
5 September 2022
Quick facts
| Lead sponsor | Kaiser Permanente |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 604 |
| Start date | 12 May 2022 |
| Primary completion | 5 September 2022 |
| Estimated completion | 8 September 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Outreach
Conditions studied
- Polyp of Colon — all drugs for Polyp of Colon →
Sponsor
Kaiser Permanente — full company profile →
Who can join
Adults 54 to 70, any sex, with Polyp of Colon. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to compare the effectiveness of three standard of care outreach approaches (i.e., mailed letter, secure message, and telephone call) on patient adoption of the new 10-year colonoscopy surveillance interval recommendation for a random sample of health plan members who have a now-outdated 5-year surveillance interval due to a finding of 1-2 small adenomas at their prior colonoscopy. The primary study endpoint is the proportion of patients in each outreach arm who adopt the new 10-year colonoscopy surveillance interval.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Randomized Trial of Patient Outreach Approaches to De-implement Outdated Colonoscopy Surveillance Intervals.
Lee JK, Koripella PC, Jensen CD, Merchant SA, et al · · 2024 · cited 2× · PMID 38191014 · DOI 10.1016/j.cgh.2023.12.027
Verify or expand the search:
- PubMed search for NCT05389397
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Outreach
Trials testing the same drug.
- NCT06666192 — The Ohio State University (OSU) SCREEN Community Program · NA · recruiting
- NCT04940442 — Outreach and Choice in Colorectal Cancer Screening · NA · unknown
Other recruiting trials for Polyp of Colon
Currently open trials in the same condition.
- NCT07007598 — Prevention of Post-Polypectomy Colorectal Bleeding by Clips in Patients on Anticoagulants · recruiting
- NCT06271941 — Reducing Neoplasia Recurrence After Endoscopic Resection of Large Colorectal Polyps · NA · recruiting
- NCT06447012 — Artificial Intelligence Development for Colorectal Polyp Diagnosis · recruiting
- NCT06822816 — Video/Image Library of Endoscopy Procedures for the Development of AI-empowered Endoscopy Quality Reporting and Educatio · recruiting
- NCT04117100 — Advanced Endo-therapeutic Procedure : Registry-based Observational Study · recruiting
Other Kaiser Permanente trials
Trials by the same sponsor.
- NCT07522645 — Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Dis · NA · not yet recruiting
- NCT07474038 — AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment · NA · enrolling by invitation
- NCT07467668 — Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure · NA · not yet recruiting
- NCT07216859 — Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI) · NA · not yet recruiting
- NCT07264062 — MetSense Pilot and Feasibility · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05389397 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kaiser Permanente
- Last refreshed: 14 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05389397.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing